Goal to boost pharma localization and innovation in the UAE
Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments, has signed four strategic Memorandums of Understanding (MoUs) during the Make it in the Emirates Forum 2025.
The agreements reinforce the UAE’s position as a regional hub for pharmaceutical innovation, localization, and advanced healthcare manufacturing.
The MoUs were signed individually with each partner, reflecting Globalpharma’s tailored approach to strategic collaboration. The agreements were concluded with four international players — PharmaPrimes Laboratories (Jordan), Nerhadou International (Egypt), Aora Health (Spain), and BioSyent Pharma (Canada).
Strategic collaborations
“The strategic collaborations announced by Globalpharma during ‘Make it in the Emirates’ reflect the UAE’s commitment to strengthening domestic pharmaceutical manufacturing and reducing reliance on imports.,” stated HE Dr. Thani Al Zeyoudi, UAE Minister of State for Foreign Trade and Chairman, Emirates Drug Establishment.
“These strategic partnerships by Globalpharma reflect the commitment to advancing the UAE’s industrial capabilities, promoting knowledge transfer, and building a resilient pharmaceutical ecosystem that supports regional health security and innovation-driven growth,” commented Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries and Masharie and Board Director, Globalpharma.
Among the signings, PharmaPrimes Laboratories, a leading CRO based in Amman, Jordan, has signed a strategic partnership with Globalpharma to establish advanced local capabilities for batch release and analysis of biosimilar drugs in the UAE.
Health needs
In another major agreement, Nerhadou International, one of Egypt’s foremost nutraceutical companies, joined forces with Globalpharma to introduce a portfolio of innovative nutraceutical and over the counter (OTC) products tailored to regional health needs.
Further expanding its footprint in the wellness space, Globalpharma entered a collaboration with Aora Health, a Spanish company known for its science-driven approach to functional supplements.
Rounding out the series of partnerships, Globalpharma signed a Licensing and Supply Agreement with BioSyent Pharma, a specialty pharmaceutical company committed to improving the lives of patients with unique and effective products in Canada and select international markets.
